Balyasny Asset Management’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-24,431
| Closed | -$2.85M | – | 2006 |
|
|
2025
Q1 | $2.85M | Sell |
24,431
-156,782
| -87% | -$18.3M | ﹤0.01% | 1038 |
|
|
2024
Q4 | $15.3M | Buy |
181,213
+119,046
| +191% | +$10.1M | 0.02% | 575 |
|
|
2024
Q3 | $5.59M | Buy |
+62,167
| New | +$5.59M | 0.01% | 824 |
|
|
2024
Q2 | – | Sell |
-9,606
| Closed | -$767K | – | 1929 |
|
|
2024
Q1 | $767K | Buy |
+9,606
| New | +$767K | ﹤0.01% | 1356 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 1766 |
|
|
2023
Q2 | – | Hold |
0
| – | – | – | 1858 |
|
|
2023
Q1 | – | Sell |
-120,874
| Closed | -$9.32M | – | 2197 |
|
|
2022
Q4 | $9.32M | Buy |
+120,874
| New | +$9.32M | 0.03% | 598 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 2346 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 2285 |
|
|
2021
Q4 | – | Sell |
-44,509
| Closed | -$1.47M | – | 1982 |
|
|
2021
Q3 | $1.47M | Buy |
+44,509
| New | +$1.47M | 0.01% | 1010 |
|
|
2020
Q4 | – | Sell |
-33,268
| Closed | -$2.37M | – | 1151 |
|
|
2020
Q3 | $2.37M | Buy |
+33,268
| New | +$2.37M | 0.02% | 627 |
|
|
2018
Q2 | – | Sell |
-14,050
| Closed | -$34K | – | 1588 |
|
|
2018
Q1 | $34K | Buy |
+14,050
| New | +$34K | ﹤0.01% | 1681 |
|